Amgen (Biotechnology) – To cut between 2,400 and 2,900 jobs

Biotechnology company Amgen (IW 600/67) announced Tuesday that it will cut between 2,400 and 2,900 jobs and shutter two facilities in the United States in a reorganization to save money.

Amgen (AMGN) plans to close facilities in Washington and Colorado as it cuts 12% to 15% of its workforce, with most of the job losses coming in the U.S.

Amgen will consolidate some staff into headquarters in Thousand Oaks, Calif., and expand in biotechnology hubs in San Francisco and Cambridge, Mass., the company said.

Chosen excerpts by Job Market Monitor. Read the whole story at Amgen to Cut Up to 15% of Workforce, Close Manufacturing Plants | Growth Strategies content from IndustryWeek.